First human efficacy study of a plant-derived influenza vaccine
-
Published:2020-11
Issue:10261
Volume:396
Page:1464-1465
-
ISSN:0140-6736
-
Container-title:The Lancet
-
language:en
-
Short-container-title:The Lancet
Reference6 articles.
1. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials;Ward;Lancet,2020
2. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18;Pebody;Euro Surveill,2019
3. Efficacy of recombinant influenza vaccine in adults 50 years of age or older;Dunkle;N Engl J Med,2017
4. Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017–2018;Izurieta;J Infect Dis,2019
5. Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness;Barr;NPJ Vaccines,2018
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献